United States · FDA National Drug Code directory
Temozolomide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-539_f519f4f0-bb62-43cb-bfc2-15f00ac1aad3
- Product NDC
- 67877-539
- Form
- CAPSULE
- Composition / generic term
- Temozolomide
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170428
- Source listing expiry
- 20261231
Source-listed ingredients
- TEMOZOLOMIDE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 5 CAPSULE in 1 BOTTLE (67877-539-07) · 67877-539-07
- 14 CAPSULE in 1 BOTTLE (67877-539-14) · 67877-539-14
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →